Sequenom Shares Drop Again | GenomeWeb
Shares in Sequenom sank by double digits for the second week in a row to lead all decliners in the BCW Index for the week ended Tuesday. Sequenom dropped 12.08 percent for the week, following a drop of 13.24 percent the week before. Though the firm has not revealed any bad news recently, Lehman Brothers dumped 1 million shares of Sequenom stock last week at a price of $4.55 per share.
Beckman Coulter led all gainers for the week with a 6.62 percent rise, followed by Illumina, which closed up 5.67 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.